Integral Health Asset Management
Latest statistics and disclosures from Integral Health Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are INSM, CYTK, THC, MLYS, VERA, and represent 35.87% of Integral Health Asset Management's stock portfolio.
- Added to shares of these 10 stocks: CYTK (+$36M), NAMS (+$28M), NVO (+$22M), ALHC (+$21M), VERA (+$16M), INSM (+$14M), CNC (+$14M), DOCS (+$13M), ACLX (+$12M), ASND (+$12M).
- Started 19 new stock positions in ARWR, DOCS, Lb Pharmaceuticals, ACLX, ISRG, LFST, PHVS, NVO, ESPR, DYN. IQV, NAMS, NVST, CNC, APLS, JNJ, ASND, DNTH, UPB.
- Reduced shares in these 10 stocks: MLYS (-$46M), QURE (-$44M), BSX (-$24M), DXCM (-$18M), EHC (-$15M), GEHC (-$15M), DGX (-$12M), ETNB (-$10M), MLTX (-$9.4M), CRL (-$8.6M).
- Sold out of its positions in ATYR, ABBV, RCUS, BAX, CPRX, DXCM, ETNB, GEHC, JSPR, MLTX. RARE, VRNA, VKTX, WAT, ALKS, CRSP.
- Integral Health Asset Management was a net buyer of stock by $80M.
- Integral Health Asset Management has $1.5B in assets under management (AUM), dropping by 35.32%.
- Central Index Key (CIK): 0001773206
Tip: Access up to 7 years of quarterly data
Positions held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 74 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Insmed Com Par $.01 (INSM) | 16.6 | $245M | +6% | 1.7M | 144.01 |
|
| Cytokinetics Com New Call Option (CYTK) | 8.0 | $118M | +43% | 2.2M | 54.96 |
|
| Tenet Healthcare Corp Com New (THC) | 4.1 | $61M | +9% | 300k | 203.04 |
|
| Mineralys Therapeutics (MLYS) | 3.8 | $57M | -44% | 1.5M | 37.92 |
|
| Vera Therapeutics Cl A (VERA) | 3.3 | $49M | +47% | 1.7M | 29.06 |
|
| Uniqure Nv SHS (QURE) | 2.4 | $35M | -55% | 600k | 58.37 |
|
| Brightspring Health Svcs (BTSG) | 2.3 | $34M | -8% | 1.2M | 29.56 |
|
| Boston Scientific Corporation (BSX) | 2.0 | $29M | -45% | 300k | 97.63 |
|
| Newamsterdam Pharma Company Ordinary Shares Put Option (NAMS) | 1.9 | $28M | NEW | 1.0M | 28.44 |
|
| Regeneron Pharmaceuticals (REGN) | 1.9 | $28M | 50k | 562.27 |
|
|
| Alignment Healthcare (ALHC) | 1.9 | $28M | +300% | 1.6M | 17.45 |
|
| Alnylam Pharmaceuticals (ALNY) | 1.9 | $27M | +9% | 60k | 456.00 |
|
| Novartis Sponsored Adr (NVS) | 1.7 | $26M | 200k | 128.24 |
|
|
| Encompass Health Corp (EHC) | 1.7 | $25M | -37% | 200k | 127.02 |
|
| Edgewise Therapeutics (EWTX) | 1.6 | $24M | +50% | 1.5M | 16.22 |
|
| Astrazeneca Sponsored Adr (AZN) | 1.6 | $23M | +50% | 300k | 76.72 |
|
| RadNet (RDNT) | 1.5 | $23M | -25% | 300k | 76.21 |
|
| Rhythm Pharmaceuticals (RYTM) | 1.5 | $22M | +83% | 220k | 100.99 |
|
| Novo-nordisk A S Adr Put Option (NVO) | 1.5 | $22M | NEW | 400k | 55.49 |
|
| Neurocrine Biosciences (NBIX) | 1.4 | $21M | 150k | 140.38 |
|
|
| Cardinal Health (CAH) | 1.4 | $20M | -7% | 130k | 156.96 |
|
| Rezolute Com New (RZLT) | 1.3 | $19M | +11% | 2.0M | 9.40 |
|
| Revolution Medicines (RVMD) | 1.3 | $19M | +23% | 400k | 46.70 |
|
| Quest Diagnostics Incorporated (DGX) | 1.1 | $16M | -43% | 85k | 190.58 |
|
| Anthem (ELV) | 1.1 | $16M | -16% | 50k | 323.12 |
|
| Elanco Animal Health (ELAN) | 1.1 | $16M | +128% | 800k | 20.14 |
|
| Edwards Lifesciences (EW) | 1.1 | $16M | 200k | 77.77 |
|
|
| Eli Lilly & Co. (LLY) | 1.0 | $15M | -20% | 20k | 763.00 |
|
| CVS Caremark Corporation (CVS) | 1.0 | $15M | -20% | 200k | 75.39 |
|
| Tarsus Pharmaceuticals (TARS) | 1.0 | $15M | +25% | 250k | 59.43 |
|
| Medtronic SHS (MDT) | 1.0 | $14M | -25% | 150k | 95.24 |
|
| Centene Corporation (CNC) | 1.0 | $14M | NEW | 400k | 35.68 |
|
| Doximity Cl A (DOCS) | 0.9 | $13M | NEW | 180k | 73.15 |
|
| Pfizer (PFE) | 0.9 | $13M | -28% | 500k | 25.48 |
|
| Penumbra (PEN) | 0.9 | $13M | +25% | 50k | 253.32 |
|
| Arcellx Common Stock (ACLX) | 0.8 | $12M | NEW | 150k | 82.10 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.8 | $12M | NEW | 60k | 198.81 |
|
| Fresenius Medical Care Sponsored Adr (FMS) | 0.8 | $12M | -40% | 450k | 26.33 |
|
| McKesson Corporation (MCK) | 0.8 | $12M | +50% | 15k | 772.54 |
|
| Agilent Technologies Inc C ommon (A) | 0.8 | $12M | +80% | 90k | 128.35 |
|
| Roivant Sciences SHS (ROIV) | 0.8 | $11M | +25% | 750k | 15.13 |
|
| Envista Hldgs Corp (NVST) | 0.8 | $11M | NEW | 550k | 20.37 |
|
| Intuitive Surgical Com New (ISRG) | 0.8 | $11M | NEW | 25k | 447.23 |
|
| Irhythm Technologies (IRTC) | 0.8 | $11M | +62% | 65k | 171.99 |
|
| EXACT Sciences Corporation (EXAS) | 0.7 | $11M | +100% | 200k | 54.71 |
|
| Upstream Bio (UPB) | 0.7 | $11M | NEW | 575k | 18.81 |
|
| Oric Pharmaceuticals (ORIC) | 0.7 | $11M | -28% | 900k | 12.00 |
|
| Regenxbio Inc equity us cm (RGNX) | 0.7 | $11M | +57% | 1.1M | 9.65 |
|
| Oscar Health Cl A (OSCR) | 0.7 | $10M | +450% | 550k | 18.93 |
|
| Dyne Therapeutics (DYN) | 0.7 | $10M | NEW | 800k | 12.65 |
|
| Biohaven (BHVN) | 0.7 | $9.8M | +116% | 650k | 15.01 |
|
| Beam Therapeutics (BEAM) | 0.7 | $9.7M | -20% | 400k | 24.27 |
|
| Charles River Laboratories (CRL) | 0.6 | $9.4M | -47% | 60k | 156.46 |
|
| Inspire Med Sys (INSP) | 0.6 | $8.9M | +71% | 120k | 74.20 |
|
| Iqvia Holdings (IQV) | 0.6 | $8.5M | NEW | 45k | 189.94 |
|
| Lifestance Health Group (LFST) | 0.6 | $8.3M | NEW | 1.5M | 5.50 |
|
| Glaukos (GKOS) | 0.6 | $8.2M | +100% | 100k | 81.55 |
|
| Arrowhead Pharmaceuticals (ARWR) | 0.5 | $7.8M | NEW | 225k | 34.49 |
|
| Acadia Healthcare (ACHC) | 0.5 | $7.4M | -25% | 300k | 24.76 |
|
| Terns Pharmaceuticals (TERN) | 0.5 | $7.1M | +35% | 950k | 7.51 |
|
| Sana Biotechnology (SANA) | 0.5 | $7.1M | +33% | 2.0M | 3.55 |
|
| Hologic (HOLX) | 0.5 | $6.7M | -20% | 100k | 67.49 |
|
| Cooper Cos (COO) | 0.4 | $6.5M | +35% | 95k | 68.56 |
|
| Protara Therapeutics Com Stk (TARA) | 0.4 | $6.1M | 1.4M | 4.35 |
|
|
| Dianthus Therapeutics (DNTH) | 0.4 | $5.9M | NEW | 150k | 39.35 |
|
| Apellis Pharmaceuticals (APLS) | 0.4 | $5.7M | NEW | 250k | 22.63 |
|
| Johnson & Johnson (JNJ) | 0.4 | $5.6M | NEW | 30k | 185.42 |
|
| Pharvaris N V (PHVS) | 0.3 | $5.0M | NEW | 200k | 24.95 |
|
| Esperion Therapeutics (ESPR) | 0.3 | $4.0M | NEW | 1.5M | 2.65 |
|
| Scholar Rock Hldg Corp (SRRK) | 0.3 | $3.7M | 100k | 37.24 |
|
|
| Nurix Therapeutics (NRIX) | 0.2 | $3.2M | +12% | 350k | 9.24 |
|
| Alto Neuroscience Com Shs (ANRO) | 0.1 | $1.6M | 400k | 4.02 |
|
|
| Lb Pharmaceuticals Com Shs | 0.1 | $1.6M | NEW | 100k | 15.79 |
|
| Tenax Therapeutics Com New (TENX) | 0.1 | $1.3M | 167k | 7.61 |
|
Past Filings by Integral Health Asset Management
SEC 13F filings are viewable for Integral Health Asset Management going back to 2019
- Integral Health Asset Management 2025 Q3 filed Nov. 14, 2025
- Integral Health Asset Management 2025 Q2 filed Aug. 14, 2025
- Integral Health Asset Management 2025 Q1 filed May 15, 2025
- Integral Health Asset Management 2024 Q4 filed Feb. 14, 2025
- Integral Health Asset Management 2024 Q3 filed Nov. 14, 2024
- Integral Health Asset Management 2024 Q2 filed Aug. 14, 2024
- Integral Health Asset Management 2024 Q1 filed May 15, 2024
- Integral Health Asset Management 2023 Q3 filed Nov. 14, 2023
- Integral Health Asset Management 2023 Q2 filed Aug. 11, 2023
- Integral Health Asset Management 2023 Q1 filed May 9, 2023
- Integral Health Asset Management 2022 Q4 filed Feb. 13, 2023
- Integral Health Asset Management 2022 Q3 filed Nov. 14, 2022
- Integral Health Asset Management 2022 Q2 filed Aug. 3, 2022
- Integral Health Asset Management 2022 Q1 filed May 12, 2022
- Integral Health Asset Management 2021 Q4 filed Feb. 2, 2022
- Integral Health Asset Management 2021 Q3 filed Nov. 12, 2021